Novo Nordisk's weight loss drugs Ozempic and Wegovy are in the spotlight in Medicare price negotiations.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights